Tatyana Trapeznikova, O. Letyaeva, Oleg . Ziganshin, Valeria Gubina
{"title":"A patient with severe acne: therapy perspectives","authors":"Tatyana Trapeznikova, O. Letyaeva, Oleg . Ziganshin, Valeria Gubina","doi":"10.25208/vdv9838","DOIUrl":null,"url":null,"abstract":"Acne is a common dermatological disease that peaks between 12 and 25. The tendency of inflammatory elements to appear on the skin, especially the face, leads to psycho-emotional imbalance and significantly reduces the patient’s quality of life. In 95% of cases, the outcome of acne is the formation of cicatricial deformities, the treatment of which often takes years. If inflammatory elements are present, treatment should be aimed at ensuring a long-term remission of the disease, including preventing the formation of new scars. \nThis work aims to determine the efficacy and safety of acne treatment using systemic isotretinoin. \nThe article presents the results of systemic isotretinoin use in severe forms of acne and acne that is resistant to standard treatments based on clinical cases. It was proved that the benefits obtained from isotretinoin usage are much more significant than the possible risk of side effects, especially if the patient’s skin tends to scar. The latest data on the etiology and pathogenesis of cicatricial deformities is presented. A review of modern techniques for the correction of post-acne cicatricial deformities was carried out. \nIsotretinoin is clinically proven to be highly effective and safety safe for both severe acne. \nThe use of isotretinoin to treat acne is effective and reduces the risk of scarring.","PeriodicalId":23618,"journal":{"name":"Vestnik dermatologii i venerologii","volume":"82 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vestnik dermatologii i venerologii","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25208/vdv9838","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Acne is a common dermatological disease that peaks between 12 and 25. The tendency of inflammatory elements to appear on the skin, especially the face, leads to psycho-emotional imbalance and significantly reduces the patient’s quality of life. In 95% of cases, the outcome of acne is the formation of cicatricial deformities, the treatment of which often takes years. If inflammatory elements are present, treatment should be aimed at ensuring a long-term remission of the disease, including preventing the formation of new scars.
This work aims to determine the efficacy and safety of acne treatment using systemic isotretinoin.
The article presents the results of systemic isotretinoin use in severe forms of acne and acne that is resistant to standard treatments based on clinical cases. It was proved that the benefits obtained from isotretinoin usage are much more significant than the possible risk of side effects, especially if the patient’s skin tends to scar. The latest data on the etiology and pathogenesis of cicatricial deformities is presented. A review of modern techniques for the correction of post-acne cicatricial deformities was carried out.
Isotretinoin is clinically proven to be highly effective and safety safe for both severe acne.
The use of isotretinoin to treat acne is effective and reduces the risk of scarring.